Vontier Corp. (VNT) Tops Q4 EPS by 2c, Revenues Beat; Offers 1Q & FY21 EPS Guidance

Go back to Vontier Corp. (VNT) Tops Q4 EPS by 2c, Revenues Beat; Offers 1Q & FY21 EPS Guidance
Savient Pharmaceuticals, Inc. (NYSE: VNT) Delayed: 32.76 -0.54 (1.62%)
Previous Close $33.30    52 Week High $9.92 
Open $33.25    52 Week Low $9.10 
Day High $33.26    P/E N/A 
Day Low $32.66    EPS $-0.94 
Volume 195,155